American Bio Medica Corporation

Equities

ABMC

US0246001087

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 10:52:56 2024-05-14 am EDT 5-day change 1st Jan Change
0.0003 USD -85.00% Intraday chart for American Bio Medica Corporation -85.00% +200.00%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
American Bio Medica Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
American Bio Medica Corporation Auditor Raises 'Going Concern' Doubt CI
American Bio Medica Corporation Announces Termination of Melissa A. Waterhouse as Principal Financial Officer CI
American Bio Medica Corporation Announces Termination of Melissa A. Waterhouse as Chief Executive Officer CI
Healgen Scientific LLC completed the acquisition of substantially all of the operating assets of American Bio Medica Corporation. CI
Healgen Scientific LLC agreed to acquire substantially all of the operating assets of American Bio Medica Corporation for $3 million. CI
American Bio Medica Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
American Bio Medica Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
American Bio Medica Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
American Bio Medica Corporation Reports Earnings Results for the Full Year Ended December 31, 2021 CI
American Bio Medica Corporation Auditor Raises 'Going Concern' Doubt CI
American Bio Medica Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
American Bio Medica Corporation announced that it has received $0.1 million in funding CI
Declaration of Voting Results by American Bio CI
John J. Moroney Engages in Discussions with American Bio Medica CI
American Bio Medica Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Earnings Flash (ABMC) AMERICAN BIO MEDICA CORPORATION Reports Q1 Loss $-0.01 MT
American Bio Medica Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2020 CI
American Bio Medica Corporation Announces Resignation of Chaim Davis from the Board of Directors CI
American Bio Medica Corporation announced that it expects to receive $0.125 million in funding from Lincoln Park Capital, LLC CI
American Bio Medica Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2020 CI
American Bio Medica : Earnings Flash (ABMC) AMERICAN BIO MEDICA CORPORATION Posts Q3 EPS $-0.01 MT
American Bio Medica Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2020 CI
American Bio Medica Corporation Reports Earnings Results for the First Quarter Ended March 31, 2020 CI
American Bio Medica Corporation Reports Earnings Results for the Full Year Ended December 31, 2019 CI
Chart American Bio Medica Corporation
More charts
American Bio Medica Corporation is engaged in the manufacturing and distribution of lateral flow immunoassay tests, primarily for the immediate detection of drugs in urine and oral fluid. The Company also distributes a number of other products related to the immediate detection of drugs and alcohol. It manufactures a number of products that detect the presence or absence of drugs in urine. It manufactures the various urine drug testing product lines, including The Rapid Drug Screen (RDS), RDS InCup, Rapid TOX, Rapid TOX Cup and Private Label Products. RDS is a patented rapid drug test that detects the presence or absence of 2-10 drugs simultaneously in a single urine specimen. RDS InCup is a drug-testing cup that detects the presence or absence of 1-12 drugs in a urine specimen. Its OralStat is a drug test for the detection of drugs in oral fluids. Its Respiratory Syncytial Virus (RSV) test does detect RSV in both children under the age of six, as well as adults over the age of 60.
More about the company
  1. Stock Market
  2. Equities
  3. ABMC Stock
  4. News American Bio Medica Corporation
  5. American Bio Medica : Earnings Flash (ABMC) AMERICAN BIO MEDICA CORPORATION Posts Q3 EPS $-0.01
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW